Provided by Tiger Trade Technology Pte. Ltd.

Inhibrx Biosciences

96.99
-0.9400-0.96%
Post-market: 96.990.00000.00%19:30 EDT
Volume:201.45K
Turnover:19.64M
Market Cap:1.42B
PE:-10.93
High:100.13
Open:99.30
Low:96.07
Close:97.93
52wk High:155.29
52wk Low:28.16
Shares:14.67M
Float Shares:8.64M
Volume Ratio:0.84
T/O Rate:2.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.8768
EPS(LYR):-9.0434
ROE:-1773.60%
ROA:-43.61%
PB:-26.86
PE(LYR):-10.72

Loading ...

Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 25, 2022

Major Issues Report

8-K - Current report
Jan 04, 2022

Major Issues Report

8-K - Current report
Dec 01, 2021

Major Issues Report

8-K - Current report
Nov 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 09, 2021

Major Issues Report

8-K - Current report
Oct 28, 2021

Major Issues Report

8-K - Current report
Oct 12, 2021

Major Issues Report

8-K - Current report
Sep 03, 2021

Major Issues Report

Inhibrx, Inc.
Sep 03, 2021

Major Issues Report

8-K - Current report
Aug 09, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 09, 2021

Major Issues Report

8-K - Current report
Jun 21, 2021

Major Issues Report

8-K - Current report
Jun 09, 2021

Major Issues Report

8-K - Current report
May 17, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals